期刊文献+

老年骨质疏松性椎体压缩性骨折PVP术后再骨折风险的列线图预测模型构建 被引量:13

Establishment of nomogram prediction model for the risk of refracture after PVP for senile osteoporotic vertebral compression fractures
下载PDF
导出
摘要 目的 分析骨质疏松性椎体压缩性骨折(OVCF)患者经皮椎体成形术(PVP)后再骨折发生影响因素,建立列线图预测模型评估术后再骨折发生风险。方法 OVCF并行PVP的患者155例根据PVP后再骨折发生情况分为再骨折组(32例)和未再骨折组(123例)。采用Logistic分析OVCF患者PVP后再骨折发生的影响因素,利用R软件绘制列线图预测模型,并对模型进行验证。结果 再骨折组年龄、骨水泥注射率、脊柱矢状面失衡比例、骨水泥椎间盘渗漏比例均明显高于未再骨折组,骨密度明显低于未再骨折组(P<0.05)。年龄、骨水泥注射率、脊柱矢状面失衡、骨水泥椎间盘渗漏是OVCF患者PVP后再骨折发生的独立危险因素(P<0.05),骨密度是保护因素(P<0.05)。受试者工作特征曲线结果显示,预测OVCF患者PVP后再骨折发生风险的曲线下面积为0.885,校准曲线斜率接近1,Hosmer-Lemeshow检验χ^(2)=2.541,P=0.960。结论 基于年龄、骨水泥注射率、脊柱矢状面失衡、骨密度、骨水泥椎间盘渗漏这5项影响因素构建预测患者术后再骨折发生风险的列线图模型区分度、准确度均较好。 Objective To analyze the influencing factors of refracture in patients with osteoporotic vertebral compression fracture(OVCF)after percutaneous vertebroplasty(PVP),the nomogram prediction model was established to evaluate the risk of postoperative refracture.Methods A total of 155 patients with OVCF and PVP were divided into refracture group(32 cases)and non refracture group(123 cases)according to whether there was refracture after PVP.Logistic regression was used to analyze the influencing factors of refracture after PVP in OVCF patients.R software was used to draw a nomogram prediction model and verify the model.Results The age,bone cement injection rate,the ratio of spinal sagittal imbalance and the ratio of bone cement intervertebral disc leakage in the refracture group were significantly higher than those in the non refracture group,and the bone density was significantly lower than that of the non refracture group(P<0.05).The age,bone cement injection rate,spinal sagittal imbalance and bone cement intervertebral disc leakage were independent risk factors for refracture after PVP in OVCF patients(P<0.05),bone mineral density was a protective factor for refracture after PVP in OVCF patients(P<0.05).Receiver operating characteristic curve results showed that the area under curve of predicting the risk of refracture after PVP in OVCF patients was 0.885,the slope of the calibration curve was close to 1,Hosmer-Lemeshow testχ^(2)=2.541,P=0.960.Conclusions Based on five influencing factors,including age,bone cement injection rate,spine sagittal imbalance,bone density and bone cement intervertebral disc leakage,a nomogram model is constructed to predict the risk of postoperative refracture in patients.The model has good discrimination and accuracy.
作者 王徐龙 魏建仝 要鹏 WANG Xu-Long;WEI Jian-Tong;YAO Peng(Department of Orthopaedics,Zhangye People′s Hospital Affiliated to Hexi College,Zhangye 734000,Gansu,China)
出处 《中国老年学杂志》 CAS 北大核心 2023年第8期1836-1839,共4页 Chinese Journal of Gerontology
基金 国家自然科学基金青年科学基金项目(No.81603156)。
关键词 骨质疏松性椎体压缩性骨折 经皮椎体成形术 再骨折 列线图 预测模型 Osteoporotic vertebral compression fracture Percutaneous vertebroplasty Refracture Nomogram Prediction model
  • 相关文献

参考文献13

二级参考文献102

  • 1范建高.中国非酒精性脂肪性肝病诊疗指南(2010年修订版)[J].中国医学前沿杂志(电子版),2012,4(7):4-10. 被引量:275
  • 2朱国英,王洪复,王莉华,翁世芳.绝经后妇女骨质疏松性骨折易发因素的流行病学研究[J].中国骨质疏松杂志,2004,10(2):172-174. 被引量:10
  • 3杨惠林,顾晓晖,陈亮,陆俭,毛海青,孟斌,牛国旗,赵刘军,唐天驷.后凸成形术治疗骨质疏松性脊柱骨折的选择性与个体化[J].中国医学科学院学报,2005,27(2):174-178. 被引量:37
  • 4陈允震,刘海春,张剑锋,谢斌.骨胶原与骨质疏松骨密度及骨生物力学的相关性研究[J].中华创伤骨科杂志,2007,9(10):955-958. 被引量:6
  • 5Wang G, Yang H, Chen K. Osteoporotic vertebral compression fractures with an intravertebral cleft treated by percutaneous balloon kyphoplasty[ J]. J Bone Joint Surg Br, 2010, 92:1553 - 1557.
  • 6Mao H, Zou J, Geng D, et al. Osteoporotic vertebral fractures without compression : key factors of diagnosis and initial outcome oftreatment with cement augmentation [ J ]. Neuroradiology, 2012, 54:1137 - 1143.
  • 7Black DM, Delmas PD, Eastell R, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis [ J ]. N Engl J Med, 2007, 356 : 1809 - 1822.
  • 8Black DM, Reid IR, Boonen S, et al. The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT) [ J]. J Bone Miner Res ,2012,27:243 - 254.
  • 9Black DM, Reid 1R, Cauley JA, et al. The effect of 6 versus 9 years of zoledronic acid treatment in osteoporosis: a randomized second extension to the HORIZON-Pivotal Fracture Trial (PFT) [ J]. J Bone Miner Res,2015,30:934 - 944.
  • 10Lyles KW, Col6n-Emeric CS, Magaziner JS, et al. Zoledronic acid and clinical fractures and mortality after hip fracture[ J]. N Engl J Med ,2007,357 : 1799 - 1809.

共引文献382

同被引文献159

引证文献13

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部